Curexo Statistics

Total Valuation

Curexo has a market cap or net worth of KRW 394.87 billion.

Market Cap	394.87B
Enterprise Value	n/a

Important Dates

The last earnings date was Friday, January 31, 2025.

Earnings Date	Jan 31, 2025
Ex-Dividend Date	n/a

Share Statistics

Curexo has 41.09 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	41.09M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.10%
Owned by Institutions (%)	2.74%
Float	26.88M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.17
PB Ratio	11.83
P/TBV Ratio	23.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.08, with a Debt / Equity ratio of 1.23.

Current Ratio	1.08
Quick Ratio	0.51
Debt / Equity	1.23
Debt / EBITDA	n/a
Debt / FCF	-0.58
Interest Coverage	-113.89

Financial Efficiency

Return on equity (ROE) is -102.15% and return on invested capital (ROIC) is -47.65%.

Return on Equity (ROE)	-102.15%
Return on Assets (ROA)	-44.52%
Return on Invested Capital (ROIC)	-47.65%
Return on Capital Employed (ROCE)	-207.38%
Revenue Per Employee	960.27M
Profits Per Employee	-556.79M
Employee Count	29
Asset Turnover	0.47
Inventory Turnover	1.75

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.60% in the last 52 weeks. The beta is 1.02, so Curexo's price volatility has been similar to the market average.

Beta (5Y)	1.02
52-Week Price Change	-42.60%
50-Day Moving Average	8,203.60
200-Day Moving Average	8,750.65
Relative Strength Index (RSI)	53.53
Average Volume (20 Days)	1,935,960

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Curexo had revenue of KRW 27.85 billion and -16.15 billion in losses. Loss per share was -607.62.

Revenue	27.85B
Gross Profit	2.70B
Operating Income	-42.58B
Pretax Income	-42.79B
Net Income	-16.15B
EBITDA	-39.24B
EBIT	-42.58B
Loss Per Share	-607.62

Full Income Statement

Balance Sheet

The company has 8.06 billion in cash and 24.93 billion in debt, giving a net cash position of -16.87 billion or -410.49 per share.

Cash & Cash Equivalents	8.06B
Total Debt	24.93B
Net Cash	-16.87B
Net Cash Per Share	-410.49
Equity (Book Value)	20.24B
Book Value Per Share	812.53
Working Capital	2.35B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -41.18 billion and capital expenditures -1.43 billion, giving a free cash flow of -42.61 billion.

Operating Cash Flow	-41.18B
Capital Expenditures	-1.43B
Free Cash Flow	-42.61B
FCF Per Share	-1,037.01

Full Cash Flow Statement

Margins

Gross margin is 9.70%, with operating and profit margins of -152.90% and -57.98%.

Gross Margin	9.70%
Operating Margin	-152.90%
Pretax Margin	-153.64%
Profit Margin	-57.98%
EBITDA Margin	-140.90%
EBIT Margin	-152.90%
FCF Margin	n/a

Dividends & Yields

Curexo does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.21%
Shareholder Yield	0.21%
Earnings Yield	-4.09%
FCF Yield	-10.79%

Stock Splits

The last stock split was on April 5, 2006. It was a forward split with a ratio of 2.

Last Split Date	Apr 5, 2006
Split Type	Forward
Split Ratio	2

Scores

Curexo has an Altman Z-Score of -1.46. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.46
Piotroski F-Score	n/a